Try our Advanced Search for more refined results

September 29, 2020

Kent v. Immunomedics, Inc. et al

Track this case

Case Number:

1:20-cv-01312

Court:

Delaware

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Maryellen Noreika

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 30, 2020

    Immunomedics Hit With Investor Suit To Halt $21B Gilead Deal

    An Immunomedics investor has filed a proposed class action in Delaware federal court seeking to halt the company's $21 billion sale to biopharmaceutical giant Gilead Sciences, saying key information has been withheld about the transaction.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login